| Role |
Name |
Disclosure |
Details |
| Author | Nadia K Waheed, MD, Consulting Staff, Department of Vitreoretinal Disease, Cole Eye Institute/Cleveland Clinic Foundation | Nothing to disclose | Details | | Coauthor | C Stephen Foster, MD, FACS, FACR, FAAO, Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Founder and President, Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institution | Nothing to disclose | Details | | Medical Editor | Russell P Jayne, MD, Consulting Vitreoretinal Surgeon, The Retina Center at Las Vegas | Nothing to disclose | Details | | Pharmacy Editor | Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles | Nothing to disclose | Details | | Managing Editor | Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Institute | Allergan Allergan Alcon Inspire RPS | Details | | CME Editor | Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri | Nothing to disclose | Details | | Chief Editor | Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences | Nothing to disclose | Details |
|